On-chip micro-flow polystyrene bead-based immunoassay for quantitative detection of tacrolimus (FK506)

被引:64
作者
Murakami, Y
Endo, T
Yamamura, S
Nagatani, N
Takamura, Y
Tamiya, E
机构
[1] Japan Adv Inst Sci & Technol, Sch Mat Sci, Dept Chem Mat Sci, Tatsunokuchi, Ishikawa 9231292, Japan
[2] Fujisawa Pharmaceut Co Ltd, Biopharmaceut & Pharmacokinet Res Labs, Yodogawa Ku, Osaka 5328514, Japan
[3] Japan Sci & Technol Agcy, Tatsunokuchi, Ishikawa 9231292, Japan
基金
日本科学技术振兴机构;
关键词
tacrolimus (FK506); microfluidics; therapeutic drug monitoring; blood concentration; competitive immunoassay;
D O I
10.1016/j.ab.2004.07.029
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Tacrolimus (FK506) is a widely used immunosuppressant for preventing allograft rejection and the treatment of atopic dermatitis. FK506 necessitates therapeutic drug monitoring because of inter- and intrapatient variability and the lack of correlation between the administered close and the blood concentration. Previous immunoassay-based methods required a relatively long assay time and troublesome liquid-handling procedures. In the present study, we aimed to establish a rapid monitoring method for FK506 determination by using a poly(dimethylsiloxane) (PDMS)-based microfluidic device. Polystyrene beads were coated with mouse anti-FK506 antibody and placed in the flow channel. As a competitive assay, sample Solution was allowed to react in the flow channel. After the addition of the fluorogenic substrate, the fluorescent signal was observed under a microscope. As a result, the developed assay allowed a short detection time of approximately 15 min per each sample and a high sensitivity even by using only a single bead. The feasibility of performing a competitive assay using a PDMS-based antibody chip gives promising results over the existing immunoassay-based methods. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 19 条
  • [1] An HPLC/MS/MS assay for tacrolimus in patient blood samples - Correlation with results of an ELISA assay
    Alak, AM
    Moy, S
    Cook, M
    Lizak, P
    Niggebiugge, A
    Menard, S
    Chilton, A
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1997, 16 (01) : 7 - 13
  • [2] Cogill JL, 1998, CLIN CHEM, V44, P1942
  • [3] Comparison of ELISA method versus MEIA method for daily practice in the therapeutic monitoring of tacrolimus
    Dietemann, J
    Berthoux, P
    Gay-Montchamp, JP
    Batie, M
    Berthoux, F
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (11) : 2246 - 2249
  • [4] FIRDAOUS I, 1995, CLIN CHEM, V41, P1292
  • [5] FUNG J, 1991, TRANSPLANT P, V23, P2977
  • [6] Gewirtz Andrew T, 2002, Curr Opin Investig Drugs, V3, P1307
  • [7] SIMPLIFIED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY ASSAY FOR MEASUREMENT OF TACROLIMUS AND ITS METABOLITES AND CROSS-VALIDATION WITH MICROPARTICLE ENZYME-IMMUNOASSAY
    GONSCHIOR, AK
    CHRISTIANS, U
    WINKLER, M
    SCHIEBEL, HM
    LINCK, A
    SEWING, KF
    [J]. THERAPEUTIC DRUG MONITORING, 1995, 17 (05) : 504 - 510
  • [8] GRENIER FC, 1991, TRANSPLANT P, V23, P2748
  • [9] ANALYSIS OF TACROLIMUS (FK-506) IN RELATION TO THERAPEUTIC DRUG-MONITORING
    JUSKO, WJ
    [J]. THERAPEUTIC DRUG MONITORING, 1995, 17 (06) : 596 - 601
  • [10] KLINTMALM GB, 1994, CLIN TRANSPLANT, V8, P207